An observational study in Obesity, Overweight and Motivation, sponsored by BiomediKcal. Completed at 1 site in Colombia. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-02.
Sponsored by BiomediKcal · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Obesity with a site in Colombia — 4 open to participants now, 5 under way, 3 of them phase 3. Obesity · Colombia.
Among the 28 studies in Obesity with a site in Colombia, this one is one of 2 that started in 2016, is one of 7 observational ones, and was the 7th registered.
11,529 studies on the registry are indexed under Obesity; 2,035 are open to participants now.
Browse Obesity studies →4 of the 28 studies in Obesity with a site in Colombia are open now. Recruiting first, the newest first:
Novo Nordisk A/S · Sites in Colombia, United States, Australia and 23 more countries
Ages 8–18
Amgen · Sites in Colombia, United States, Argentina and 32 more countries
Ages 18–99
Hospital Universitario San Ignacio · Sites in Colombia
Ages 18+
Dynamical Business and Science Society - DBSS International SAS · Sites in Colombia
Ages 18–60 · Healthy volunteers
A study can be open while its sites in Colombia have not opened yet or have stopped. Only those recruiting at a site in Colombia →
Of the 1,336 Obesity studies recruiting now, 377 (28%) set no upper age limit and 856 (64%) stop at 75 or younger; 166 take children under 18; 488 take healthy volunteers.
This study: 18 Years to 99 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 2 started in 2016.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 110 is close to the median of 115 across 2,157 observational studies indexed under Obesity.
Median enrollment 100 across the 21 interventional studies, 378 across the 7 observational. Of the 20 that completed or were terminated, 3 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 28 have an industry lead sponsor. The 10 most frequent:
BiomediKcal is the lead sponsor of 3 studies on the registry; none are open to participants now.
BiomediKcal has 3 studies filed under Obesity — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 28 studies in Obesity with a site in Colombia, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study evaluates patient response to a motivation evolution chart for a medical-nutrition intervention as a continuation of a previous study: adherence to an overweight and obesity treatment available at: https://www.ncbi.nlm.nih.gov/pubmed/25101227
Overweight and obese participants who consulted a medical nutrition clinic
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Photographic follow-up every 4 weeks
Other: Lifestyle-medicine intervention
Evolution registration by photograph
To register Body Image of patients regarding results to a medical nutrition treatment
Time frame: 16 weeks
Plan to share: No
Ran from Oct 2016 to primary completion in Sep 2017, 11 months.
Of 792 non-industry observational studies under Obesity, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 106. This study's 11 months is below that.
Counting every sponsor, half of 837 studies reached it within 39 months; a quarter within 17 and three quarters within 96.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.